Actual Medicinal Product (AMP) Buscopan 10mg tablets (Opella POM UK Ltd)

Stability Information

(Some stability information inherited from generic)

Stability

Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.

Notes

Protect from light, protect from moisture.

Provenance

This compatibility recommendation is derived from Buscopan 10mg tablets (Sanofi).

Generic

Hyoscine butylbromide

Formulation

Hyoscine butylbromide 10mg tablets

Alternative Suppliers (16)

Buscopan 10mg tablets (Opella POM UK Ltd)

Buscopan IBS Relief 10mg tablets (Opella Healthcare UK Ltd)

Buscopan Cramps 10mg tablets (Opella Healthcare UK Ltd)

Buscopan 10mg tablets (Sigma Pharmaceuticals Plc)

Hyoscine butylbromide 10mg tablets (Morningside Healthcare Ltd)

Hyoscine butylbromide 10mg tablets (A A H Pharmaceuticals Ltd)

Hyoscine butylbromide 10mg tablets (Alliance Healthcare (Distribution) Ltd)

Buscopan 10mg tablets (Dowelhurst Ltd)

Buscopan 10mg tablets (Waymade Healthcare Plc)

Buscopan 10mg tablets (DE Pharmaceuticals)

Buscopan 10mg tablets (Lexon (UK) Ltd)

Hyoscine butylbromide 10mg tablets (Medihealth (Northern) Ltd)

Hyoscine butylbromide 10mg tablets (Ria Generics Ltd)

Sigmopan 10mg tablets (Ria Generics Ltd)

Sigmopan Cramps Relief 10mg tablets (Ria Generics Ltd)

Sigmopan IBS Relief 10mg tablets (Ria Generics Ltd)

Related Formulations (2)

Hyoscine butylbromide 10mg tablets

Hyoscine butylbromide 20mg tablets